(Q50910869)

English

Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.

scientific article published in March 2013

Statements

Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit